Cardio Diagnostics Holdings has submitted an acceleration request to the SEC's Division of Corporation Finance for its Registration Statement on Form S-3 (File No. 333-284775). The company seeks to have the registration statement declared effective on February 14, 2025, at 5 p.m. Eastern Time, or as soon as practicable thereafter.The request, filed pursuant to Rule 461 under the Securities Act of 1933, includes provisions for oral confirmation of effectiveness through the company's legal counsel, Shartsis Friese LLP. The filing represents a significant step in the company's regulatory compliance and securities registration process.

Cardio Diagnostics Holdings has submitted an acceleration request to the SEC's Division of Corporation Finance for its Registration Statement on Form S-3 (File No. 333-284775). The company seeks to have the registration statement declared effective on February 14, 2025, at 5 p.m. Eastern Time, or as soon as practicable thereafter.The request, filed pursuant to Rule 461 under the Securities Act of 1933, includes provisions for oral confirmation of effectiveness through the company's legal counsel, Shartsis Friese LLP. The filing represents a significant step in the company's regulatory compliance and securities registration process.